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Background
Mastocytosis is a rare disease affecting both children and
adults. It is characterized by accumulation of mast-cells
in the skin and/or other tissues so that two main variants
are distinguished: cutaneous (CM) and systemic (SM)
mastocytosis. Most pediatric patients have primarily CM
and complete remission will develop in a considerable
number of patients during puberty. Less frequently, skin
lesions persist and these patients are often diagnosed
with SM in adulthood.
Our study investigates the correlation between
SCORMA (SCORing MAstocytosis) Index (SC-I), a scor-
ing system that assesses the clinical extent and intensity
of cutaneous mastocytosis, and Grading system, that eval-
uates skin-specific symptoms and treatment status, in the
follow-up of pediatric patients with mastocytosis. Further-
more, we evaluate the role of SC-I modifications in the
assessment of the severity of disease.
Methods
Twenty-two patients aged less than 12 years were enrolled
from our centre. SC-I and Grading were assessed for each
patient at first visit and after 2 years, with determination
of Grading modifications and calculation of differences in
absolute value of SC-I (ΔSC-I). Data were analyzed using
SPSS software. Pearson’s correlation coefficient (r) was
used to assess the relationship between SC-I and Grading
at first visit (r1) and after 2 years (r2). Chi-square test was
performed to evaluate the association of ΔSC-I with
Grading modifications, by dividing patients with SC-I
changed (ΔSC-I > 10) and unchanged (ΔSC-I ≤ 10) in two
groups (Grading modified and unmodified).
Results
We found r1= 0, 47 (p < 0,05) and r2 =0,36 (p < 0,05),
while there was no statistical difference in ΔSC-I in the
two groups (p < 0,05).
Conclusion
According to our data, in pediatric patients with mastocy-
tosis SC-I and Grading show a moderate correlation
at first visit which weakens not significantly at the subse-
quent assessment after 2 years. Moreover, SC-I modifica-
tions (ΔSC-I) seem to be independent from Grading
modifications and, as a consequence, from the clinical
evolution of disease.
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